1M16 image
Deposition Date 2002-06-17
Release Date 2003-08-05
Last Version Date 2024-02-14
Entry Detail
PDB ID:
1M16
Title:
Human Acidic Fibroblast Growth Factor. 141 Amino Acid Form with Amino Terminal His Tag and Leu 44 Replaced with Phe (L44F), Leu 73 Replaced with Val (L73V), Val 109 Replaced with Leu (V109L) and Cys 117 Replaced with Val (C117V).
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.24
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:acidic fibroblast growth factor
Gene (Uniprot):FGF1
Mutations:L44F, L73V, V109L, C117V
Chain IDs:A, B
Chain Length:146
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Accommodation of a highly symmetric core within a symmetric protein superfold
Protein Sci. 12 2704 2718 (2003)
PMID: 14627732 DOI: 10.1110/ps.03374903

Abstact

An alternative core packing group, involving a set of five positions, has been introduced into human acidic FGF-1. This alternative group was designed so as to constrain the primary structure within the core region to the same threefold symmetry present in the tertiary structure of the protein fold (the beta-trefoil superfold). The alternative core is essentially indistinguishable from the WT core with regard to structure, stability, and folding kinetics. The results show that the beta-trefoil superfold is compatible with a threefold symmetric constraint on the core region, as might be the case if the superfold arose as a result of gene duplication/fusion events. Furthermore, this new core arrangement can form the basis of a structural "building block" that can greatly simplify the de novo design of beta-trefoil proteins by using symmetric structural complementarity. Remaining asymmetry within the core appears to be related to asymmetry in the tertiary structure associated with receptor and heparin binding functionality of the growth factor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures